Your institution may have access to this item. Find your institution then sign in to continue.
Title
Regarding HER2‐Amplified Biliary Tract Cancer.
Abstract
This letter to the editor focuses on promising data that led to a phase II study in HER2‐amplified biliary tract cancer that is now open globally for enrollment (NCT04466891).